Sinocelltech Group (SHSE:688520) Other Income (Expense) : ¥-475 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Other Income (Expense)?

Sinocelltech Group's other income expense for the Sinocelltech Group's pretax income for the three months ended in Mar. 2024 was ¥-128 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-475 Mil.

Sinocelltech Group Other Income (Expense) Historical Data

The historical data trend for Sinocelltech Group's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Other Income (Expense) Chart

Sinocelltech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

Get a 7-Day Free Trial

6.26

9.82

-2.81

-166.36

-447.69

Sinocelltech Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-100.35	-52.76	-152.53	-142.05	-127.72

Sinocelltech Group Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-475 Mil.

Sinocelltech Group (SHSE:688520) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Sinocelltech Group (SHSE:688520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176

Website

http://www.sinocelltech.com

Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

Executives

Xie Liang Zhi

Director

Sinocelltech Group (SHSE:688520) Headlines

No Headlines